BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 31485913)

  • 21. Estimation of an EORTC QLU-C10 Value Set for Spain Using a Discrete Choice Experiment.
    Finch AP; Gamper E; Norman R; Viney R; Holzner B; King M; Kemmler G;
    Pharmacoeconomics; 2021 Sep; 39(9):1085-1098. PubMed ID: 34216380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The EORTC QLU-C10D discrete choice experiment for cancer patients: a first step towards patient utility weights.
    Gamper EM; King MT; Norman R; Loth FLC; Holzner B; Kemmler G;
    J Patient Rep Outcomes; 2022 May; 6(1):42. PubMed ID: 35507194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Responsiveness and convergent validity of QLU-C10D and EQ-5D-3L in assessing short-term quality of life following esophagectomy.
    Bulamu NB; Vissapragada R; Chen G; Ratcliffe J; Mudge LA; Smithers BM; Isenring EA; Smith L; Jamieson GG; Watson DI;
    Health Qual Life Outcomes; 2021 Oct; 19(1):233. PubMed ID: 34600554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The EORTC QLU-C10D is a valid cancer-specific preference-based measure for cost-utility and health technology assessment in the Netherlands.
    Pilz MJ; Seyringer S; Hallsson LR; Bottomley A; Jansen F; King MT; Norman R; Rutten MJ; Leeuw IMV; Siersema PD; Gamper EM
    Eur J Health Econ; 2024 Mar; ():. PubMed ID: 38483665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The EORTC QLU-C10D was more efficient in detecting clinical known group differences in myelodysplastic syndromes than the EQ-5D-3L.
    Gamper EM; Cottone F; Sommer K; Norman R; King M; Breccia M; Caocci G; Patriarca A; Palumbo GA; Stauder R; Niscola P; Platzbecker U; Caers J; Vignetti M; Efficace F
    J Clin Epidemiol; 2021 Sep; 137():31-44. PubMed ID: 33753228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Health state utility differed systematically in breast cancer patients between the EORTC QLU-C10D and the PROMIS Preference Score.
    Klapproth CP; Fischer F; Rose M; Karsten MM
    J Clin Epidemiol; 2022 Dec; 152():101-109. PubMed ID: 36162712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Health utility assessments in individuals undergoing diagnostic and surveillance colonoscopy: improved discrimination with a cancer-specific scale.
    Bulamu NB; Chen G; McGrane E; Cock C; Young GP; Symonds EL
    Cancer Causes Control; 2024 Feb; 35(2):347-357. PubMed ID: 37747615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of EQ-5D-3L with QLU-C10D in Metastatic Melanoma Using Cost-Utility Analysis.
    Kim H; Cook G; Goodall S; Liew D
    Pharmacoecon Open; 2021 Sep; 5(3):459-467. PubMed ID: 33891268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thresholds for clinical importance for four key domains of the EORTC QLQ-C30: physical functioning, emotional functioning, fatigue and pain.
    Giesinger JM; Kuijpers W; Young T; Tomaszewski KA; Friend E; Zabernigg A; Holzner B; Aaronson NK
    Health Qual Life Outcomes; 2016 Jun; 14():87. PubMed ID: 27267486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The EORTC Quality of Life Questionnaire for cancer patients (QLQ-C30): Australian general population reference values.
    Mercieca-Bebber R; Costa DS; Norman R; Janda M; Smith DP; Grimison P; Gamper EM; King MT
    Med J Aust; 2019 Jun; 210(11):499-506. PubMed ID: 31155722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Updated EORTC QLQ-C30 general population norm data for Germany.
    Nolte S; Waldmann A; Liegl G; Petersen MA; Groenvold M; Rose M;
    Eur J Cancer; 2020 Sep; 137():161-170. PubMed ID: 32777715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A brief instrument to measure health-related quality-of-life in patients with bone metastasis: validation of the German version of Bone Metastases Quality-of-Life-10 (BOMET-QoL-10).
    Marschner N; Wilke J; Reschke D; Kaiser F; Schmoor C; Grugel R; Boller E
    J Med Econ; 2018 Sep; 21(9):920-929. PubMed ID: 29874105
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Normative data of the EORTC QLQ-C30 for the German population: a population-based survey.
    Waldmann A; Schubert D; Katalinic A
    PLoS One; 2013; 8(9):e74149. PubMed ID: 24058523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation and comparison of the health-related quality-of-life instruments EORTC QLQ-C30 and SF-36 in assessment of patients with chronic nonmalignant pain.
    Fredheim OM; Borchgrevink PC; Saltnes T; Kaasa S
    J Pain Symptom Manage; 2007 Dec; 34(6):657-65. PubMed ID: 17618079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
    Park KU
    Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. General Spanish population normative data analysis for the EORTC QLQ-C30 by sex, age, and health condition.
    Arraras JI; Nolte S; Liegl G; Rose M; Manterola A; Illarramendi JJ; Zarandona U; Rico M; Teiejria L; Asin G; Hernandez I; Barrado M; Vera R; Efficace F; Giesinger JM;
    Health Qual Life Outcomes; 2021 Aug; 19(1):208. PubMed ID: 34461909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of two quality-of-life instruments for cancer patients: the functional assessment of cancer therapy-general and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30.
    Kemmler G; Holzner B; Kopp M; Dünser M; Margreiter R; Greil R; Sperner-Unterweger B
    J Clin Oncol; 1999 Sep; 17(9):2932-40. PubMed ID: 10561373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The European Organization for Research and Treatment of Cancer QLQ-C30: an examination into the cultural validity and reliability of the Turkish version of the EORTC QLQ-C30.
    Guzelant A; Goksel T; Ozkok S; Tasbakan S; Aysan T; Bottomley A
    Eur J Cancer Care (Engl); 2004 May; 13(2):135-44. PubMed ID: 15115469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Erratum to: QLU-C10D: a health state classification system for a multi-attribute utility measure based on the EORTC QLQ-C30.
    King MT; Costa DSJ; Aaronson NK; Brazier JE; Cella DF; Fayers PM; Grimison P; Janda M; Kemmler G; Norman R; Pickard AS; Rowen D; Velikova G; Young TA; Viney R
    Qual Life Res; 2016 Oct; 25(10):2683. PubMed ID: 27060088
    [No Abstract]   [Full Text] [Related]  

  • 40. Predictive factors of overall well-being using the EORTC QLQ-C15-PAL extracted from the EORTC QLQ-C30.
    Lam K; Zeng L; Zhang L; Tseng LM; Hou MF; Fairchild A; Vassiliou V; Jesus-Garcia R; Alm El-Din MA; Kumar A; Forges F; Chie WC; Sahgal A; Poon M; Chow E
    J Palliat Med; 2013 Apr; 16(4):402-8. PubMed ID: 23458649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.